PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Pharmaceutics and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.\', \'Laboratorio de Farmacología, Centro de Investigación Veterinaria de Tandil (CIVETAN) (UNCPBA-CICPBA-CONICET), Facultad de Ciencias Veterinarias, UNCPBA, Tandil, Argentina.\', \'Division of Pharmaceutics and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. Electronic address: gaurirao@live.unc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0022-3549(20)30495-010.1016/j.xphs.2020.08.024
?:hasPublicationType
?:journal
  • Journal of pharmaceutical sciences
is ?:pmid of
?:pmid
?:pmid
  • 32891630
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.984
?:rankingScore_hIndex
  • 149
is ?:relation_isRelatedTo_publication of
?:title
  • Development of a Minimal Physiologically-Based Pharmacokinetic Model to Simulate Lung Exposure in Humans Following Oral Administration of Ivermectin for COVID-19 Drug Repurposing.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all